Gallbladder Cancer Market Growth Accelerated by Rising Incidence of Gallbladder Cancer


 The gallbladder is a small organ located under the liver which stores and concentrates bile. Gallbladder cancer occurs due to abnormal and uncontrolled cell growth in the gallbladder. Symptoms associated with gallbladder cancer include abdominal pain, jaundice and vomiting which often lead to its diagnosis. The global Gallbladder Cancer Market is estimated to be valued at US$ 1,607.47 Mn in 2023 and is expected to exhibit a CAGR of 5.3% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.

Market key trends:
Increasing Geriatric Population
The key trend driving the growth of the gallbladder cancer market is the rising geriatric population across the globe. As age is a significant risk factor for gallbladder cancer, with majority cases being diagnosed in people aged over 65 years. According to WHO, the world's population aged over 65 years is projected to double from 2021 to 2050. This growing geriatric demographic will significantly propel the demand for effective gallbladder cancer treatment drugs and devices over the forecast period.

Segment Analysis
The global gallbladder cancer market is segmented by type, diagnosis, treatment, end user and region. By type, the papillary adenocarcinoma segment is expected to dominate the market during the forecast period. Papillary adenocarcinoma makes up around 70-80% of gallbladder cancers and has slightly better survival rates compared to other types of gallbladder cancer such as adenocarcinoma and squamous cell carcinoma.

Key Takeaways
The global gallbladder cancer market is expected to witness high growth over the forecast period of 2023 to 2030. Driven by rising incidence rates of gallbladder cancer worldwide and increasing research for more effective therapies.

Regional analysis: The North America region currently dominates the global gallbladder cancer market and is expected to continue its dominant position during the forecast period. This can be attributed to factors such as high research funding, increasing gallbladder cancer prevalence and growing awareness about the disease. The Asia Pacific region is projected to witness the fastest growth during the forecast period owing to rapidly developing healthcare infrastructure and rising healthcare expenditure in emerging economies of the region.

Key players operating in the gallbladder cancer market are Histogen Inc., Cipla Limited, Aclaris Therapeutics, Inc., Merck & Co., Inc., Daiichi-Sankyo Co., Ltd., Johnson and Johnson Services, Inc., Lexington International LLC, Vita-Cos-Med Klett-Loch GmbH, PureTech, Vitabiotics, Dr. Reddyâ€TMs Laboratories, HCell Inc., Follica, Inc. and Ranbaxy Laboratories Ltd. Companies are focusing on developing newer targeted therapies and combination treatments to improve clinical outcomes of gallbladder cancer patients.

Comments

Post a Comment

Popular posts from this blog

Unveiling Health Secrets: Exploring the Potential of Blood-Based Biomarkers

Image
  The human body is a complex and intricate system, often harboring subtle signs of its inner workings. One of the most promising avenues for unlocking these secrets lies within our bloodstream – a treasure trove of information encoded in the form of blood-based biomarkers. These biomarkers, measurable indicators present in the blood, hold the potential to revolutionize healthcare by providing early detection, accurate diagnosis, and personalized treatment approaches. Blood-based biomarkers encompass a wide range of molecules – from proteins and nucleic acids to metabolites and even circulating cells. Researchers have been diligently working to identify specific biomarkers associated with various diseases and conditions. For instance, elevated levels of certain proteins might point to cardiovascular diseases, while specific genetic material could indicate the presence of cancer. By analyzing these biomarkers, clinicians gain valuable insights into an individual's health status, en...
Read more

Revolutionizing Biology: Advancements in Single Cell Analysis Techniques

Image
  Single cell analysis has emerged as a groundbreaking technology that is revolutionizing the field of biology. Traditionally, biological studies were conducted on populations of cells, averaging out the heterogeneity present within them. However, the advent of single cell analysis has enabled scientists to delve into the complexity of individual cells, uncovering a wealth of previously inaccessible information. Advancements in single cell analysis techniques have paved the way for a deeper understanding of cellular heterogeneity, gene expression, and cellular behavior. One of the most remarkable techniques is single-cell RNA sequencing (scRNA-seq), which allows scientists to measure gene expression in individual cells. This breakthrough has led to the identification of rare cell types, understanding of cellular communication networks, and the discovery of novel biomarkers. Moreover, single cell imaging techniques, such as single cell fluorescence microscopy, have enabled research...
Read more

Medical Robots Market Poised to Grow Owing to Improving Healthcare Infrastructure

Image
 The Medical Robots Market is anticipated to witness robust growth due to rising healthcare spending across the globe. Medical robots are used to perform minimal invasive surgeries with greater accuracy and flexibility. Growing preference for Robot-Assisted Surgery (RAS) over conventional open surgeries due to benefits such as shorter recovery time and minimum operative scars has been augmenting demand for medical robots. Key functions include guiding and positioning surgical accessories like guide tubes in radiology and guiding catheter and wires in cardiology. With rising chronic disease prevalence associated with aging populations, the need for more surgical procedures is surging which requires precise action minimally invasive robotic systems can provide. The Global Medical Robots Market is estimated to be valued at US$ 11.47 Bn in 2024 and is expected to exhibit a CAGR of 16% over the forecast period 2023 to 2030. Key Takeaways: Key players operating in the Medical Robo...
Read more